Protective Effect of Nimodipine Against Valproic-acid Induced Biochemical and Behavioral Phenotypes of Autism

키워드

참고문헌 (72)

1. Baio J, "Prevalence of autism spectrum disorder among children aged 8 years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014", MMWR Surveill Summ, 67, pp.1~23 (2018)
2. Markram K, "Abnormal fear conditioning and amygdala processing in an animal model of autism", Neuropsychopharmacology, 33, pp.901~912 (2008)
3. Barrett CE, "Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally", Mol Autism, 8, pp.42~ (2017)
4. Yaoyu Pu, "Autism-like Behaviors in Male Juvenile Offspring after Maternal Glyphosate Exposure", Clinical Psychopharmacology and Neuroscience, 19(3), pp.554~558 (2021), 대한정신약물학회[DOI]
5. Hirsch MM, "Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism", Neuropharmacology, 167, pp.107930~ (2020)
6. Li J, "Genetic evidence for possible involvement of the calcium channel gene CACNA1A in autism pathogenesis in Chinese Han population", PLoS One, 10, pp.e0142887~ (2015)
7. Luhach K, "Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder", J Pharm Pharmacol, 73, pp.1460~1469 (2021)
8. Santocchi E, "Gut to brain interaction in Autism Spectrum Disorders : a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters", BMC Psychiatry, 16, pp.183~ (2016)
9. Jane Pei-Chen Chang, "Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents", Clinical Psychopharmacology and Neuroscience, 18(4), pp.469~483 (2020), 대한정신약물학회[DOI]
10. Eda Sünnetçi, "Effects of the Prenatal Administration of Tetanus Toxoid on the Sociability and Explorative Behaviors of Rat Offspring: A Preliminary Study", Clinical Psychopharmacology and Neuroscience, 19(1), pp.84~92 (2021), 대한정신약물학회[DOI]
11. Kazlauskas N, "Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation : relevance for susceptibility and resilience in autism", Psychoneuroendocrinology, 110, pp.104441~ (2019)
12. Luhach K, "Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD", Eur J Pharmacol, 890, pp.173663~ (2021)
13. Kumar H, "Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats", Brain Res, 1630, pp.83~97 (2016)
14. Pinggera A, "CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels", Biol Psychiatry, 77, pp.816~822 (2015)
15. Despang P, "Autism-associated mutations in the CaVβ2 calcium-channel subunit increase Ba2+-currents and lead to differential modulation by the RGK-protein Gem", Neurobiol Dis, 136, pp.104721~ (2020)
16. Rosenberg EC, "Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain", Neurobiol Dis, 116, pp.120~130 (2018)
17. Carlson AP, "Nimodipine reappraised : an old drug with a future", Curr Neuropharmacol, 18, pp.65~82 (2020)
18. Li B, "Sequential ionic and conformational signaling by calcium channels drives neuronal gene expression", Science, 351, pp.863~867 (2016)
19. Tao J, "Phosphorylation of MeCP2 at serine 80 regulates its chromatin association and neurological function", Proc Natl Acad Sci U S A, 106, pp.4882~4887 (2009)
20. Kumar H, "Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder", Neurochem Int, 91, pp.34~45 (2015)
21. Hajisoltani R, "Hyperexcitability of hippocampal CA1pyramidal neurons in male offspring of a rat model of autism spectrum disorder(ASD)induced by prenatal exposure to valproic acid : a possible involvement of Ih channel current", Brain Res, 1708, pp.188~199 (2019)
22. Ansari MA, "Effects of nimodipine, vinpocetine and their combination on isoproterenolinduced myocardial infarction in rats", Biomed Pharmacother, 109, pp.1372~1380 (2019)
23. Desai RA, "Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis", Ann Neurol, 88, pp.123~136 (2020)
24. Wang HY, "Protective effect of Naoxintong Capsule(NXTC, 脑心通胶囊)combined with Guhong Injection(GHI, 谷红注射液)on rat brain microvascular endothelial cells during cerebral ischemia-reperfusion injury", Chin J Integr Med, 27, pp.744~751 (2021)
25. Mishra PR, "Effect of nimodipine on morphine-related withdrawal syndrome in rat model : an observational study", J Pediatr Neurosci, 12, pp.7~14 (2017)
26. Kim KC, "The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats", Toxicol Lett, 201, pp.137~142 (2011)
27. Kumar H, "Safe and sustainable use of arsenic-contaminated aquifers in the Gangetic Plain", pp.97~107 (2015), Springer
28. Kumar H, "Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats", Brain Res Bull, 124, pp.27~39 (2016)
29. Chauhan A, "Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism", J Neurochem, 117, pp.209~220 (2011)
30. Mirza R, "Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats", Life Sci, 214, pp.106~117 (2018)
31. Manaenko A, "Comparison Evans Blue injection routes : Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model", J Neurosci Methods, 195, pp.206~210 (2011)
32. Barak B, "Neurobiology of social behavior abnormalities in autism and Williams syndrome", Nat Neurosci, 19, pp.647~655 (2016)
33. Luhach K, "Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress", Autism Res, 14, pp.2270~2286 (2021)
34. Bathina S, "Brain-derived neurotrophic factor and its clinical implications", Arch Med Sci, 11, pp.1164~1178 (2015)
35. Bourtchuladze R, "Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein", Cell, 79, pp.59~68 (1994)
36. de la Torre-Ubieta L, "Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain", Neuron, 72, pp.22~40 (2011)
37. Wu H, "Fingolimod(FTY720)attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism", Life Sci, 173, pp.43~54 (2017)
38. Koskimäki J, "Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex", Cell Mol Neurobiol, 35, pp.189~196 (2015)
39. Kany S, "Cytokines in inflammatory disease", Int J Mol Sci, 20, pp.6008~ (2019)
40. Codagnone MG, "Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism", Dev Neurosci, 37, pp.215~231 (2015)
41. Pober JS, "Inflammation and the blood microvascular system", Cold Spring Harb Perspect Biol, 7, pp.a016345~ (2014)
42. Wei H, "IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation", J Neuroinflammation, 8, pp.52~ (2011)
43. de Theije CG, "Intestinal inflammation in a murine model of autism spectrum disorders", Brain Behav Immun, 37, pp.240~247 (2014)
44. Abdel-Fattah MM, "Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia", reperfusion injury : an experimental trial in rats, 2018, pp.391, 1003~1020
45. Sanz JM, "Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia", Br J Pharmacol, 167, pp.1702~1711 (2012)
46. Zamora NN, "Deletion of voltage-gated calcium channels in astrocytes during demyelination reduces brain inflammation and promotes myelin regeneration in mice", J Neurosci, 40, pp.3332~3347 (2020)
47. Li S, "Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion", Brain Res, 1712, pp.207~216 (2019)
48. Chen LH, "Neuroprotective effects of nimodipine and MK-801 on acute infectious brain edema induced by injection of pertussis bacilli to neocortex of rats", Chin J Traumatol, 6, pp.118~123 (2003)
49. Weber MD, "Repeated social defeat, neuroinflammation, and behavior : monocytes carry the signal", Neuropsychopharmacology, 42, pp.46~61 (2017)
50. Nadeem A, "Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children", Brain Behav Immun, 67, pp.335~344 (2018)
51. Frye RE, "Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders", Pediatr Res, 69(5 Pt 2), pp.41~ (2011)[DOI]
52. Rossignol DA, "Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism", Front Physiol, 5, pp.150~ (2014)
53. James SJ, "Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism", Am J Clin Nutr, 80, pp.1611~1617 (2004)
54. Seung Min Bae, "The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder", Clinical Psychopharmacology and Neuroscience, 16(2), pp.129~135 (2018), 대한정신약물학회[DOI]
55. Zhang Y, "Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive", stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid, 2015, pp.35, 263~270
56. Kwan V, "Wnt signaling networks in autism spectrum disorder and intellectual disability", J Neurodev Disord, 8, pp.45~ (2016)
57. Kumar H, "Remediate Effect of ryanodine receptor antagonist in valproic-acid induced autism", Biomed Pharmacol J, 15, pp.59~71 (2022)
58. Kumar H, "Shielding effect of ryanodine receptor modulator in rat model of autism", Basic Clin Neurosci J (2021)[DOI]
59. Frye RE, "Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder", Transl Psychiatry, 3, pp.e220~ (2013)
60. Morakotsriwan N, "Autistic-like behaviors, oxidative stress status, and histopathological changes in cerebellum of valproic acid rat model of autism are improved by the combined extract of purple rice and silkworm pupae", Oxid Med Cell Longev, 2016, pp.3206561~ (2016)
61. Zhang Y, "Downregulating the canonical Wnt", β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress, 2012, pp.37, 1409~1419
62. Kamasak K, "Effects of Nimodipine and Nigella sativa on oxidative stress and apoptosis in serum and brain tissue of rats with experimental head trauma", Turk Neurosurg, 31, pp.8~17 (2021)
63. Leisz S, "Nimodipine-dependent protection of Schwann cells, astrocytes and neuronal cells from osmotic, oxidative and heat stress is associated with the activation of AKT and CREB", Int J Mol Sci, 20, pp.4578~ (2019)
64. Fiorentino M, "Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders", Mol Autism, 7, pp.49~ (2016)
65. Sorby-Adams AJ, "The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system(CNS)Injury", Int J Mol Sci, 18, pp.1788~ (2017)
66. Dong B, "Hemopexin alleviates cognitive dysfunction after focal cerebral ischemia-reperfusion injury in rats", BMC Anesthesiol, 19, pp.13~ (2019)
67. Lochhead JJ, "Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation", J Cereb Blood Flow Metab, 30, pp.1625~1636 (2010)
68. Rakkar K, "Increases in intracellular calcium perturb blood-brain barrier via protein kinase C-alpha and apoptosis", Biochim Biophys Acta, 1862, pp.56~71 (2016)
69. Brown RC, "Calcium modulation of adherens and tight junction function : a potential mechanism for blood-brain barrier disruption after stroke", Stroke, 33, pp.1706~1711 (2002)
70. Shutov L, "The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats", Cell Mol Neurobiol, 26, pp.1541~1557 (2006)
71. 전세진, "Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder", Experimental Neurobiology, 27(5), pp.321~343 (2018), 한국뇌신경과학회
72. Darine Froy N. Mabunga, "Exploring the Validity of Valproic Acid Animal Model of Autism", Experimental Neurobiology, 24(4), pp.285~300 (2015), 한국뇌신경과학회

관련 논문AI추천